Proton therapy (66 GyRBE in 10 fractions over 2 weeks or 72.6 GyRBE in 22 fractions over 4.4 weeks)
Sponsors
Nagoya City University West Medical Center
Conditions
Stage I non-small cell lung cancer
Phase 2
A phase 2 study of proton therapy for operable stage I non-small cell lung cancer
Active, not recruitingJPRN-UMIN000045505
Start: 2013-06-20Target: 39Updated: 2026-06-29
A phase 2 study of proton therapy for inoperable stage I non-small cell lung cancer
Active, not recruitingJPRN-UMIN000045504
Start: 2013-08-13Target: 57Updated: 2026-06-29